65 I B, drugs, pharmaceuticals, & hematology related products, FSS contract award

Active Awarded Last action

Contract number
36F79723D0171
Awardee
Awarding agency
Task orders
5

Award facts

Opportunity
  • 65IB Solicitation number
Last date to order 64% complete
IDV ceiling
$15,835,898.75
Award type
Multiple award
Who can order
All agencies
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price with Economic Price Adjustment

Award details come from SAM.gov/FPDS.

About this IDV

GSA awarded a Federal Supply Schedule contract to Partner Therapeutics, Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) schedule on August 15, 2023, with a contract ceiling of $15,835,898.75 and performance through August 14, 2028.

The contract is a multiple-award vehicle with no set-aside category. Place of performance is Lexington, Massachusetts. The schedule covers drugs, pharmaceuticals, and hematology-related products. The contract includes an evergreen clause option to extend provision.

Recent ordering activity under this Schedule demonstrates substantial government utilization. On September 26, 2023, the Office of the Assistant Secretary for Preparedness and Response (ASPR) issued a delivery order valued at $99.3 million for 14,635 units of LEUKINE 250MCG VIL INJ at a firm fixed unit price of $1,079.60 per unit, with completion targeted for September 29, 2027. On April 10, 2026, Veterans Integrated Service Network 6 issued a delivery order valued at $36,281.40 for emergency business engagement medications for veterans, completed April 24, 2026.

Partner Therapeutics specializes in medical countermeasures and critical pharmaceuticals, with particular expertise in therapeutics for neutropenia, sepsis, and other urgent medical conditions. The company serves federal agencies including the Department of Veterans Affairs, the Department of Defense, and the Department of Health and Human Services through its pharmaceutical supply and development capabilities.

Task orders

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00006 · Changes related to evergreen clause option to extend provision $0
Supplemental Agreement for work within scope P00005 · 2026 public law pricing updates $0
Supplemental Agreement for work within scope P00004 · Lifecycle update $0
Supplemental Agreement for work within scope P00003 · Product addition $0
Supplemental Agreement for work within scope P00002 · 2025 public law pricing updates $0
Supplemental Agreement for work within scope P00001 · 2024 public law pricing updates $0
Original award $0

Quick answers

Who was awarded contract 36F79723D0171?

36F79723D0171 was awarded to Partner Therapeutics, Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on August 15, 2023.

How much is contract 36F79723D0171 worth?

36F79723D0171's own ceiling is $15,835,899.

How many orders have been placed under contract 36F79723D0171?

5 orders have been placed under 36F79723D0171, the latest on September 4, 2026.

Who can order from contract 36F79723D0171?

36F79723D0171 is a multiple award federal supply schedule. All agencies can place orders on it.

Is contract 36F79723D0171 part of a contract vehicle?

Yes. 36F79723D0171 is part of Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36F79723D0171 competed?

The extent of competition for 36F79723D0171 was full and open competition.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV